Presentation is loading. Please wait.

Presentation is loading. Please wait.

Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?

Published byAubrey Davidson Modified over 8 years ago

Similar presentations

Presentation on theme: "Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?"— Presentation transcript:

1 Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?

2 Richard Shih, MD, FACEP Emergency Medicine Associates Atlantic City, NJ September 26-27, 2006

3 Richard Shih, MD, FACEP 2006 Advanced Emergency & Acute Care Medicine and Technology Conference 2006 Advanced Emergency & Acute Care Medicine and Technology Conference

4 Richard Shih, MD, FACEP Richard Shih, MD, FACEP Program Director Department of Emergency Medicine Morristown Memorial Hospital, Morristown, NJ

5 Richard Shih, MD, FACEP Disclosures All past advisory board or speakers’ bureau activities have expired within the past year All past advisory board or speakers’ bureau activities have expired within the past year

6 Richard Shih, MD, FACEP Sessions Objectives Discuss the NINDS study results Discuss the NINDS study results Discuss the Follow-up studies to NINDS Discuss the Follow-up studies to NINDS Discuss the NINDS reanalysis Discuss the NINDS reanalysis

7 Richard Shih, MD, FACEP Case Presentation… 55 yo M presents to ED Weakness on his left side “Couldn’t grasp cup of coffee or key” Symptoms began 30 minutes Hx NIDDM, smoker No recent illness

8 Richard Shih, MD, FACEP Give TPA? Code Grey Code Grey Radiology resident read of CT Radiology resident read of CT Stat Neurology consult? Stat Neurology consult? Standard of care? Standard of care? Medicolegal risk? Medicolegal risk?

9 Richard Shih, MD, FACEP

10 The NINDS Study TPA works for acute stroke!! TPA works for acute stroke!! TPA causes IC bleed TPA causes IC bleed 3 hour window: TIA or stroke mimic 3 hour window: TIA or stroke mimic NINDS:only (+) study NINDS:only (+) study only enrolled 624 patients sicker pts in placebo group

11 Richard Shih, MD, FACEP Thrombolytic Clinical Trials Initial IV streptokinase studies failed: MAST-E (Europe), MAST-1 (Italy), ASK (Australia): Initial IV streptokinase studies failed: MAST-E (Europe), MAST-1 (Italy), ASK (Australia): (-) benefit; [6 hr window] (-) benefit; [6 hr window] Initial IV TPA trial: ECASS (Europe): Initial IV TPA trial: ECASS (Europe): (-) benefit. However, selected subgroups may benefit; [6 hr window] (-) benefit. However, selected subgroups may benefit; [6 hr window] Next IV TPA trial: NINDS (US): Next IV TPA trial: NINDS (US): (+) benefit; [dose finding & 3 hr window] (+) benefit; [dose finding & 3 hr window]

12 Richard Shih, MD, FACEP The NINDS Study 3 hr treatment window 3 hr treatment window TPA dose: 0.9 mg/kg (max 90 mg) TPA dose: 0.9 mg/kg (max 90 mg) 10%: bolus 10%: bolus 90%:IV infusion over 1 hr 90%:IV infusion over 1 hr TPA patients with 30% greater chance for minimal or no disability (at 3 mo) TPA patients with 30% greater chance for minimal or no disability (at 3 mo) Increased IC bleed risk (0.6 vs 6.4%) Increased IC bleed risk (0.6 vs 6.4%)

13 Richard Shih, MD, FACEP NINDS Follow-up Studies NINDS (+) at 1 yr follow-up NINDS (+) at 1 yr follow-up Other follow-ups studies: Other follow-ups studies: STARS study: JAMA 2000 STARS study: JAMA 2000 Cleveland experience: JAMA 2000 Cleveland experience: JAMA 2000 Trouillas et al: Stroke 1998 Trouillas et al: Stroke 1998 Buchan et al: Neurology 2000 Buchan et al: Neurology 2000 Grond et al: Stroke 1998 Grond et al: Stroke 1998 Chiu et al: Stroke 1998 Chiu et al: Stroke 1998 TPA stroke survey group: Neurology 1999 TPA stroke survey group: Neurology 1999 Oregon Experience: J Stroke Cerebrovasc Dis 1999 Oregon Experience: J Stroke Cerebrovasc Dis 1999 Wirkowski et al: J Stroke Cerebrovasc Dis 1999 Wirkowski et al: J Stroke Cerebrovasc Dis 1999

14 Richard Shih, MD, FACEP Pooled Analysis Hacke et al: Lancet 2004 Hacke et al: Lancet 2004 Graham GD: Stroke 2003 Graham GD: Stroke 2003 IC bleed is the main risk IC bleed is the main risk Risk at ~ 5.2% Risk at ~ 5.2%

15 Richard Shih, MD, FACEP

16 NINDS Reanalysis Subgroup patient assignment Subgroup patient assignment 91-180 minute treatment arm (worse Px) 91-180 minute treatment arm (worse Px) Placebo group had sicker patients in this are (NIHSS < 5: 19 vs 4%) Placebo group had sicker patients in this are (NIHSS < 5: 19 vs 4%) Study results reaffirmed Study results reaffirmed

17 Richard Shih, MD, FACEPConclusions TPA for CVA data support its use in selected patients NINDS study data has been debated thoroughly

18 Richard Shih, MD, FACEP Questions? www.FERNE.org shih100@yahoo.com 973-971-5800 ferne_ema_2006_shih_tpa3hour_092606_finalcd 2/8/2016 11:05 PM

Download ppt "Richard Shih, MD, FACEP Stroke Patient Management Using IV tPA: When and How Should It Be Utilized in ED Patients?"

Similar presentations

Patient Recruitment Patient Recruitment Thomas Devlin, MD PhD Erlanger Southeast Regional Stroke Center.

Patient Recruitment Patient Recruitment Thomas Devlin, MD PhD Erlanger Southeast Regional Stroke Center.
3/28/2017© 2009, American Heart Association. All rights reserved.

3/28/2017© 2009, American Heart Association. All rights reserved.
Heather M. Prendergast, MD, MPH EMRA/FERNE Case Conference: Legal Issues in the ED Management of Acute Ischemic Stroke Patients.

Heather M. Prendergast, MD, MPH EMRA/FERNE Case Conference: Legal Issues in the ED Management of Acute Ischemic Stroke Patients.
Accomplishments in Stroke Care

Accomplishments in Stroke Care
TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.

TPA in Stroke: What's All the Fuss?. FERNE Brain Illness and Injury Course.
The NINDS rt-PA Stroke Trial Prior information(Pre-Clinical, Phase I Studies, etc) Thrombolytic canalization of occluded arteries may reduce the degree.

The NINDS rt-PA Stroke Trial Prior information(Pre-Clinical, Phase I Studies, etc) Thrombolytic canalization of occluded arteries may reduce the degree.
Target: Stroke Building on Success A national quality improvement initiative of the American Heart Association/American Stroke Association to improve.

Target: Stroke Building on Success A national quality improvement initiative of the American Heart Association/American Stroke Association to improve.
Edward P. Sloan, MD, MPH FERNE/EMRA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.

Edward P. Sloan, MD, MPH FERNE/EMRA Session: Treating Ischemic Stroke Patients Using a 3 to 4.5 Hour tPA Window.
EM TREATMENT OF ACUTE STROKE Progress, Problems, Politics William G. Barsan, M.D. University of Michigan.

EM TREATMENT OF ACUTE STROKE Progress, Problems, Politics William G. Barsan, M.D. University of Michigan.
Richard Shih, MD, FACEP Stroke Patient and ED Stroke Therapy Assessments: What Does Every Emergency Physician Need to Know About the NIHSS & Other Stroke.

Richard Shih, MD, FACEP Stroke Patient and ED Stroke Therapy Assessments: What Does Every Emergency Physician Need to Know About the NIHSS & Other Stroke.
Edward P. Sloan, MD, MPH, FACEP ED Ischemic Stroke Patient Management: Optimal Diagnostic and Treatment Strategies.

Edward P. Sloan, MD, MPH, FACEP ED Ischemic Stroke Patient Management: Optimal Diagnostic and Treatment Strategies.
Edward P. Sloan, MD, MPH, FACEP Emergency Department Neurological Patient Emergencies: Optimizing Patient Outcomes, Minimizing Medical Legal Risk.

Edward P. Sloan, MD, MPH, FACEP Emergency Department Neurological Patient Emergencies: Optimizing Patient Outcomes, Minimizing Medical Legal Risk.
Optimal Management of Hypertensive Emergency Patients: Clinical Scenarios and Panel Discussion.

Optimal Management of Hypertensive Emergency Patients: Clinical Scenarios and Panel Discussion.
Edward P. Sloan, MD, MPH, FACEP Stroke Patient Care in the Prehospital and ED Settings: Should EMS Triage & Inter-hospital Transfer Occur?

Edward P. Sloan, MD, MPH, FACEP Stroke Patient Care in the Prehospital and ED Settings: Should EMS Triage & Inter-hospital Transfer Occur?
Scott Silvers, MD, FACEP Treating ED Ischemic Stroke Patients: NIHSS Approximation & Elevated BP Management.

Scott Silvers, MD, FACEP Treating ED Ischemic Stroke Patients: NIHSS Approximation & Elevated BP Management.
Edward P. Sloan, MD, MPH ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?

Edward P. Sloan, MD, MPH ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?
J. Stephen Huff, MD ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED? (mimics, stroke scales, timing, and CT.

J. Stephen Huff, MD ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED? (mimics, stroke scales, timing, and CT.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.

Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.

Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.

Maximizing IV Thrombolytic Therapy in Acute Ischemic Stroke Kamakshi Lakshminarayan, MD PhD Assistant Professor Neurology & Epidemiology University of.

Similar presentations

Ads by Google